In order to address this, in vitro activation of human NK cells with IL-12, IL-15, and IL-18 has been found to result in enhanced IFNγ production with effective killing of cancer cells in vitro as well as in an in vivo mouse model of ovarian cancer [398]. Here, IFNG is linked to cancer.